Anthony Epstein

This article is about the scientist. For the American judge, see Anthony C. Epstein.

Sir
Anthony Epstein
CBE FRS FMedSci
Born
Michael Anthony Epstein

(1921-05-18)18 May 1921
London, England
Died6 February 2024(2024-02-06) (aged 102)
London, England
EducationSt Paul's School, London
Alma mater
Known forEpstein–Barr virus
Spouse
Lisbeth Knight
​
​
(m. 1950; sep. 1965)​
Children3
Awards
Scientific career
FieldsVirology
Institutions
Doctoral studentsYvonne Barr

Sir Michael Anthony Epstein CBE FRS FMedSci (18 May 1921 – 6 February 2024) was a British pathologist and academic. He was one of the discoverers of the Epstein–Barr virus, along with Yvonne Barr and Bert Achong.[1][2][3][4][5][6][7][8]

  1. ^ Bornkamm, G. W.; Delius, H.; Zimber, U.; Hudewentz, J.; Epstein, M. A. (1980). "Comparison of Epstein–Barr virus strains of different origin by analysis of the viral DNAs". Journal of Virology. 35 (3): 603–618. doi:10.1128/JVI.35.3.603-618.1980. PMC 288854. PMID 6252328.
  2. ^ North, J. R.; Morgan, A. J.; Thompson, J. L.; Epstein, M. A. (1982). "Purified Epstein-Barr virus Mr 340,000 glycoprotein induces potent virus-neutralizing antibodies when incorporated in liposomes". Proceedings of the National Academy of Sciences of the United States of America. 79 (23): 7504–7508. Bibcode:1982PNAS...79.7504N. doi:10.1073/pnas.79.23.7504. PMC 347368. PMID 6296836.
  3. ^ Gaston, J. S.; Rickinson, A. B.; Yao, Q. Y.; Epstein, M. A. (1986). "The abnormal cytotoxic T cell response to Epstein–Barr virus in rheumatoid arthritis was correlated with disease activity and occurs in other arthropathies". Annals of the Rheumatic Diseases. 45 (11): 932–936. doi:10.1136/ard.45.11.932. PMC 1002022. PMID 2878645.
  4. ^ Epstein, M. A.; Morgan, A. J. (1983). "Clinical consequences of Epstein–Barr virus infection and possible control by an anti-viral vaccine". Clinical and Experimental Immunology. 53 (2): 257–271. PMC 1535689. PMID 6309441.
  5. ^ Rickinson, A. B.; Finerty, S.; Epstein, M. A. (1982). "Interaction of Epstein–Barr virus with leukaemic B cells in vitro. I. Abortive infection and rare cell line establishment from chronic lymphocytic leukaemic cells". Clinical and Experimental Immunology. 50 (2): 347–354. PMC 1536694. PMID 6295671.
  6. ^ Rickinson, A. B.; Crawford, D.; Epstein, M. A. (1977). "Inhibition of the in vitro outgrowth of Epstein–Barr virus-transformed lymphocytes by thymus-dependent lymphocytes from infectious mononucleosis patients". Clinical and Experimental Immunology. 28 (1): 72–79. PMC 1540876. PMID 193663.
  7. ^ Yao, Q. Y.; Rickinson, A. B.; Gaston, J. S.; Epstein, M. A. (1986). "Disturbance of the Epstein-Barr virus-host balance in rheumatoid arthritis patients: A quantitative study". Clinical and Experimental Immunology. 64 (2): 302–310. PMC 1542331. PMID 3017620.
  8. ^ Epstein, M. A.; Randle, B. J.; Finerty, S.; Kirkwood, J. K. (1986). "Not all potently neutralizing, vaccine-induced antibodies to Epstein-Barr virus ensure protection of susceptible experimental animals". Clinical and Experimental Immunology. 63 (3): 485–490. PMC 1577551. PMID 3011324.